Skip to main content
Perspective:
Perspective
04 Feb 2022

Episode #21: Embedding environmental sustainability into pharma’s DNA

Life Sciences Connect

The Future of Diagnostics Reports
The Future of Diagnostics Reports

On this episode of Life Sciences Connect podcast, we bring the discussion of emission reduction to the forefront. Hear our guest discuss further:

James Gregson – UK’s Life Sciences & Healthcare industry leader

At the start of October we launched our report: Embedding environmental sustainability into pharma’s DNA. In this episode, we explore the pressing challenges facing pharma in achieving ambitious environmental sustainability targets and evaluate ways of making progress through easy wins across the value chain, culture changes and new investment.

These quick wins can provide the license to make transformative, fundamental changes that are necessary to achieve pharma’s targets.

Listen to hear more on this topic.

 

Find out more

If you are interested in any of the topics discussed during this episode and want more information, please explore some useful links below:

Life Sciences Connect

To see the full collections of episodes so far, please visit the Life Sciences Connect podcast library. 

Listen and subscribe to Life Sciences Connect

Did you find this useful?

Yes
No

Thanks for your feedback

If you would like to help improve Deloitte.com further, please complete a 3-minute survey

Your feedback is important to us

To tell us what you think, please update your settings to accept analytics and performance cookies.

Need help updating cookies?

Speakers

Karen Taylor

Director
+44 (0)20 7007 3680

James Gregson

Partner
+44 (0)20 7007 8866

Recommendations

Episode #24: The Future of Diagnostic Imaging | Deloitte UK

Episode 24 podcast explores some of the themes highlighted in our two reports on the future of diagnostics and specifically how the adoption of innovation and new models of service delivery are transforming diagnostic imaging.
Perspective
minute read

Episode #23: Measuring the return from pharmaceutical innovation report 2022 | Deloitte UK

Karen and the team explore the findings from the annual Seize the digital momentum 2022 report. The flagship Deloitte report has provided insights into the state of biopharma R&D since 2010, with the data set expanding over the years to cover the top 20 pharma companies by R&D spend.
Perspective
minute read

Life Sciences Connect | Deloitte UK

Life Sciences Connect explores the big issues, the emerging trends and the cutting edge innovations that are shaping the Life Sciences industry. Each month, we will connect with industry experts and leaders from the Biotech, Pharmaceutical and Medical Devices industries to discuss how key trends, explored in our research reports, are charting a new, sustainable future for the Life Sciences Industry.
Collection

Embedding environmental sustainability into pharma's DNA

The pharmaceutical industry’s involvement in environmental issues is multifaceted, with implications for the entire product value chain. From research and development (R&D) and supply chain (procurement, manufacturing, transportation, logistics and other services), to patient engagement, modes of delivery and the disposal of products, all aspects of the process are affected.
Research
minute read